Guillain-Barré syndrome. A severe case calling for intensive treatment.

Postgrad Med

Kaiser Foundation Research Institute, Department of Medical Editing, Oakland, CA 94612-3429, USA.

Published: March 1997

Guillain-Barré syndrome is a relatively common disease with a low mortality rate. Early recognition and institution of treatment lead to a more favorable outcome, especially in more severe cases. Because the patient's condition may deteriorate rapidly, it is crucial to keep the patient in the hospital until his or her condition is confirmed to be stable. Plasmapheresis improves symptoms when instituted within 2 weeks of symptom onset. Treatment with high-dose intravenous immune globulin produces similar results. Speed of recovery varies, but often occurs in a few weeks or months.

Download full-text PDF

Source
http://dx.doi.org/10.3810/pgm.1997.03.189DOI Listing

Publication Analysis

Top Keywords

guillain-barré syndrome
8
syndrome severe
4
severe case
4
case calling
4
calling intensive
4
intensive treatment
4
treatment guillain-barré
4
syndrome common
4
common disease
4
disease low
4

Similar Publications

Pulmonary arterial hypertension (PAH) is a syndrome characterized by increased pulmonary vascular resistance and elevated pulmonary artery pressure, ultimately leading to right heart failure and even death. Increasing evidence implicates the fat mass and obesity-associated protein (FTO) in various metabolic and inflammatory pathways; however, its role in pulmonary endothelial function and PAH remains largely unexplored. In this study, we examined the effects of endothelial cell-specific FTO knockout on PAH development.

View Article and Find Full Text PDF

Background: Insomnia is a prevalent sleep disorder affecting millions worldwide, with significant impacts on daily functioning and quality of life. While traditionally assessed through subjective measures such as the Insomnia Severity Index (ISI), the advent of wearable technology has enabled continuous, objective sleep monitoring in natural environments. However, the relationship between subjective insomnia severity and objective sleep parameters remains unclear.

View Article and Find Full Text PDF

Atypical mycobacteria can cause rare and atypical infections of the hand. We report the case of an immunocompetent 46-year-old male initially presenting with thumb felon and progressively developing symptoms of carpal tunnel syndrome, tenosynovitis of multiple fingers and a sporotrichoid lymphocutaneous infection causing chronic cutaneous lesions all over the body. We would like to highlight the diagnostic and therapeutic difficulties of these atypical infections, which mimic other conditions and can cause a lot of morbidity.

View Article and Find Full Text PDF

Pelvic Venous Disorder (PEVD) and May-Thurner syndrome (MTS) represent relatively understudied vascular issues that can significantly impact patients' quality of life. This study aims to evaluate the efficacy of surgical treatment for PEVD and MTS, conduct a comparative analysis of outcomes, and determine the practical significance of different therapeutic approaches. The study was conducted from 2019 to 2022 in Moscow, Russia, encompassing two outpatient clinics.

View Article and Find Full Text PDF

Antibodies to β2-glycoprotein I (β2GPI) cause thrombosis in antiphospholipid syndrome, however the role of β2GPI in coagulation in vivo is not understood. To address this issue, we developed β2GPI-deficient mice (Apoh-/-) by deleting exon 2 and 3 of Apoh using CRISPR/Cas9 and compared the development of thrombosis in wild-type (WT) and Apoh-/- mice using rose bengal and FeCl3-induced carotid thrombosis, laser-induced cremaster arteriolar injury, and inferior vena cava (IVC) stasis models. We also compared tail bleeding times and activation of platelets from WT and Apoh-/- mice in the absence and presence of β2GPI.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!